Goodwin Biotechnology
Plantation
About Goodwin Biotechnology
GBI is a full-service CDMO that provides a Single-Source SolutionTM to adapt to biologics manufacturing projects at all stages, including process tech transfer, scale-up, and cGMP manufacturing of the bulk drug substance and vialed drug product for preclinical and early phase through late-phase clinical trials and commercial use. The company offers a wide range of mammalian cell culture development and manufacturing services, all of which are intended to keep your project on schedule and on track.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Private
- Employees: 51 – 100
- Estimated revenue: $10K – $50K
- Total funding: $20.7M
- Last round: Series Unknown (Apr 2019)
- Website: goodwinbio.com
- Phone: 800-814-8600
Industries & Categories
Biotechnology, Medical
Social Profiles
Canonical: https://fsome.com/organization/goodwin-biotechnology-91313 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.